Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb single-arm study of intratumoral PTS injection for advanced liver cancer
ChiCTR-ONC-12002943Phase 2Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of para-toluenesulfonamide in liver cancer and hepatic metastasis, sponsored by Peking University Cancer Hospital & Institute. Primary endpoints: Efficacy evaluation, Enhanced CT efficacy evaluation of tumor blood flow and 1 more. Started Jul 2005; status: completed.
02
Drugs
para-toluenesulfonamide
03
Conditions
liver cancerhepatic metastasis
Beyond the preview
Go deeper on ChiCTR-ONC-12002943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002943.